ProShare Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $125K | Sell |
45,615
-7,700
| -14% | -$24.4K | ﹤0.01% | 1677 |
|
|
2025
Q4 | $197K | Buy |
53,315
+11,988
| +29% | +$38.7K | ﹤0.01% | 1727 |
|
|
2025
Q3 | $110K | Sell |
41,327
-7,020
| -15% | -$13.6K | ﹤0.01% | 1828 |
|
|
2025
Q2 | $47.6K | Sell |
48,347
-1,448
| -3% | -$1.45K | ﹤0.01% | 1998 |
|
|
2025
Q1 | $71.7K | Sell |
49,795
-12,754
| -20% | -$23.5K | ﹤0.01% | 1898 |
|
|
2024
Q4 | $138K | Buy |
62,549
+26,843
| +75% | +$62.6K | ﹤0.01% | 1996 |
|
|
2024
Q3 | $58.9K | Buy |
+35,706
| New | +$72.1K | ﹤0.01% | 1957 |
|
|
2023
Q2 | – | Sell |
-13,989
| Closed | -$22.2K | – | 1865 |
|
|
2023
Q1 | $22.2K | Sell |
13,989
-1,594
| -10% | -$8.23K | ﹤0.01% | 1726 |
|
|
2022
Q4 | $97.1K | Buy |
15,583
+2,643
| +20% | +$18.9K | ﹤0.01% | 1654 |
|
|
2022
Q3 | $88K | Buy |
12,940
+948
| +8% | +$6.51K | ﹤0.01% | 1587 |
|
|
2022
Q2 | $76K | Sell |
11,992
-5,340
| -31% | -$30.3K | ﹤0.01% | 1652 |
|
|
2022
Q1 | $81K | Buy |
17,332
+7,317
| +73% | +$31.4K | ﹤0.01% | 2068 |
|
|
2021
Q4 | $50K | Buy |
+10,015
| New | +$80.2K | ﹤0.01% | 2285 |
|
|
2021
Q3 | – | Sell |
-11,875
| Closed | -$251K | – | 2086 |
|
|
2021
Q2 | $251K | Buy |
11,875
+1,092
| +10% | +$26.3K | ﹤0.01% | 2002 |
|
|
2021
Q1 | $302K | Buy |
10,783
+748
| +7% | +$22.1K | ﹤0.01% | 1799 |
|
|
2020
Q4 | $261K | Buy |
10,035
+2,380
| +31% | +$71.3K | ﹤0.01% | 1704 |
|
|
2020
Q3 | $285K | Sell |
7,655
-277
| -3% | -$11K | ﹤0.01% | 1210 |
|
|
2020
Q2 | $407K | Buy |
+7,932
| New | +$332K | ﹤0.01% | 1057 |
|
|
2020
Q1 | – | Sell |
-9,341
| Closed | -$557K | – | 1300 |
|
|
2019
Q4 | $557K | Sell |
9,341
-853
| -8% | -$38.4K | ﹤0.01% | 1011 |
|
|
2019
Q3 | $374K | Sell |
10,194
-85
| -0.8% | -$3.37K | ﹤0.01% | 1108 |
|
|
2019
Q2 | $478K | Sell |
10,279
-1,321
| -11% | -$62K | ﹤0.01% | 1031 |
|
|
2019
Q1 | $466K | Buy |
11,600
+102
| +0.9% | +$4.58K | ﹤0.01% | 1039 |
|
|
2018
Q4 | $529K | Sell |
11,498
-2,232
| -16% | -$108K | ﹤0.01% | 927 |
|
|
2018
Q3 | $609K | Sell |
13,730
-541
| -4% | -$24.8K | ﹤0.01% | 1025 |
|
|
2018
Q2 | $559K | Sell |
14,271
-192
| -1% | -$9.7K | ﹤0.01% | 1058 |
|
|
2018
Q1 | $1.05M | Sell |
14,463
-2,168
| -13% | -$159K | 0.01% | 799 |
|
|
2017
Q4 | $1.09M | Buy |
16,631
+991
| +6% | +$53.4K | 0.01% | 797 |
|
|
2017
Q3 | $784K | Buy |
15,640
+2,728
| +21% | +$132K | 0.01% | 797 |
|
|
2017
Q2 | $598K | Sell |
12,912
-774
| -6% | -$28.5K | 0.01% | 891 |
|
|
2017
Q1 | $483K | Sell |
13,686
-3,512
| -20% | -$80.4K | 0.01% | 1018 |
|
|
2016
Q4 | $215K | Buy |
17,198
+1,564
| +10% | +$18.6K | ﹤0.01% | 1558 |
|
|
2016
Q3 | $217K | Sell |
15,634
-2,899
| -16% | -$32.9K | ﹤0.01% | 1309 |
|
|
2016
Q2 | $183K | Buy |
18,533
+238
| +1% | +$3.94K | ﹤0.01% | 1445 |
|
|
2016
Q1 | $309K | Sell |
18,295
-1,725
| -9% | -$27.7K | ﹤0.01% | 1194 |
|
|
2015
Q4 | $446K | Buy |
+20,020
| New | +$505K | 0.01% | 1088 |
|
|
2014
Q4 | – | Sell |
-9,800
| Closed | -$240K | – | 2022 |
|
|
2014
Q3 | $240K | Sell |
9,800
-1,811
| -16% | -$28.8K | ﹤0.01% | 1854 |
|
|
2014
Q2 | $184K | Sell |
11,611
-4,774
| -29% | -$69K | ﹤0.01% | 2207 |
|
|
2014
Q1 | $248K | Buy |
+16,385
| New | +$254K | ﹤0.01% | 2367 |
|
Other funds holding ESPR
WA
TSC
O
VCM
